| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/05/2011 | CA2328522C Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support |
| 07/05/2011 | CA2288994C Polyalkylene oxide-modified single chain polypeptides |
| 07/05/2011 | CA2220133C Recombinant vesiculoviruses and their uses |
| 07/05/2011 | CA2204636C Diagnostic method and kit for determining kell blood group genotype |
| 06/30/2011 | WO2011078384A1 Method for measuring human insulin and measurement reagent |
| 06/30/2011 | WO2011078351A1 Secretion signal sequence, and protein expression system utilizing same |
| 06/30/2011 | WO2011078250A1 Radiolabeled compound directable in vivo to target tissue and use thereof |
| 06/30/2011 | WO2011077075A1 Orthogonal q-ribosomes |
| 06/30/2011 | WO2011060613A9 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof |
| 06/30/2011 | WO2011057239A3 Secretory protein biomarkers for high efficiency protein expression |
| 06/30/2011 | WO2011057011A3 T-cell stimulating protein b and methods of use |
| 06/30/2011 | WO2011050262A3 Dual variable domain immunoglobulins and uses thereof |
| 06/30/2011 | WO2010074821A8 Acidothermus celluloyticus xylanase |
| 06/30/2011 | US20110162115 Recombinant ndv antigen and uses thereof |
| 06/30/2011 | US20110162114 Selection method ii |
| 06/30/2011 | US20110162113 Antibodies |
| 06/30/2011 | US20110162093 Methods for producing antibodies |
| 06/30/2011 | US20110160445 Heparin-Binding Growth Factor (HBGF) Polypeptides |
| 06/30/2011 | US20110160246 Neurodegenerative Protein Aggregation Inhibition Methods and Compounds |
| 06/30/2011 | US20110160135 Suppression of neuroendocrine diseases |
| 06/30/2011 | US20110160124 Antimicrobial protein compositions and production therefor from marine bacteria |
| 06/30/2011 | US20110160081 functional complementation assay for defined gpcr oligomers |
| 06/30/2011 | US20110159543 Scalable process for culturing per.c6 cells and producing products therefrom |
| 06/30/2011 | US20110159542 Immunosuppressive polypeptides and nucleic acids |
| 06/30/2011 | US20110159541 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression |
| 06/30/2011 | US20110159540 Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins |
| 06/30/2011 | US20110159539 Method for producing recombinant proteins with a constant content of pco2 in the medium |
| 06/30/2011 | US20110159538 Process for Preparation of Insulin Compounds |
| 06/30/2011 | US20110159537 Synthetic pathway enzymes for the production of argyrins |
| 06/30/2011 | US20110159130 Reduction of endotoxin in polysialic acids |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159021 Xbp1, cd138, and cs1 peptides |
| 06/30/2011 | US20110159018 Complement factor h-derived short consensus repeat-antibody constructs |
| 06/30/2011 | US20110159015 Human antibodies to human angiopoietin-like protein 4 |
| 06/30/2011 | US20110159012 Method for isolating neural cells using tenascin-r compounds |
| 06/30/2011 | US20110159009 Anti-vegf antibodies |
| 06/30/2011 | US20110159008 Antibodies Binding To The Extracellular Domain Of The Receptor Tyrosine Kinase ALK |
| 06/30/2011 | US20110159003 Ligands That Bind Il-4 and/or Il-13 |
| 06/30/2011 | US20110158998 Helminth antigen and immunotherapy |
| 06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
| 06/30/2011 | US20110158994 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
| 06/30/2011 | US20110158988 Antibodies against extracellular domains 2 and 3 or her2 |
| 06/30/2011 | US20110158981 Methods and Compositions for Inhibiting Binding of IgE to a High Affinity Receptor |
| 06/30/2011 | US20110158977 Immunogenic compositions for Chlamydia trachomatis |
| 06/30/2011 | US20110155605 Apo-2 ligand |
| 06/30/2011 | CA2785678A1 Human insulin assay and assay reagent |
| 06/30/2011 | CA2785266A1 Orthogonal q-ribosomes |
| 06/29/2011 | EP2339350A1 Arrays |
| 06/29/2011 | EP2339344A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
| 06/29/2011 | EP2339017A2 Enhanced protein expression in bacillus |
| 06/29/2011 | EP2339016A2 Enhanced protein expression in bacillus |
| 06/29/2011 | EP2339015A1 Methods for altering protein production rates |
| 06/29/2011 | EP2339014A1 Methods and compositions comprising non-natural amino acids |
| 06/29/2011 | EP2339013A1 Methods for producing modified glycoproteins |
| 06/29/2011 | EP2339004A1 Optimizing glycan processing in plants |
| 06/29/2011 | EP2339003A2 APO-2 ligand substitutional variants |
| 06/29/2011 | EP2339002A1 Fibroblast growth factor homologs |
| 06/29/2011 | EP2338915A2 Anti-VEGF antibodies |
| 06/29/2011 | EP2338911A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 06/29/2011 | EP2338896A2 Use of lignin peroxidase in skin and hair lightening |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338512A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/29/2011 | EP2338507A1 Method of treating malignancies through induction of blood immune responses |
| 06/29/2011 | EP2337846A1 Non-natural amino acid replication-dependent microorganisms and vaccines |
| 06/29/2011 | EP2337801A2 Muc1* antibodies |
| 06/29/2011 | EP2337787A1 Clarification process |
| 06/29/2011 | EP1523496B1 Recombinant production of mixtures of antibodies |
| 06/29/2011 | CN1918298B Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 06/29/2011 | CN1875111B Production of high mannose proteins in plant culture |
| 06/29/2011 | CN1606565B Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/29/2011 | CN102112878A Device for detection of influenza virus |
| 06/29/2011 | CN102112623A FVIII muteins for treatment of von willebrand disease |
| 06/29/2011 | CN102112622A Methods and compositions for production of recombinant protein in HBx-expressing mammalian cells |
| 06/29/2011 | CN102112606A Constructs and methods for the production and secretion of polypeptides |
| 06/29/2011 | CN102112150A Yeast strain for the production of proteins with terminal alpha-1, 3-linked galactose |
| 06/29/2011 | CN102108374A Method for processing type-II collagen mixture by using poultry sternal cartilages as raw materials |
| 06/29/2011 | CN102108353A Magnetic nano-particle immobilized basic protease and preparation method and application thereof |
| 06/29/2011 | CN102108098A Crocodile collagen, and preparation and use thereof |
| 06/29/2011 | CN101503728B Method for extracting composite polypeptide liquid from mackerel bone |
| 06/29/2011 | CN101492708B Method for preparing vegetable seed peptide with single bioactivity by mix bacterium solid state fermentation |
| 06/28/2011 | US7968696 Viral interleukin-6 |
| 06/28/2011 | US7968695 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses |
| 06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 06/28/2011 | US7968690 Agonist anti-trkC antibodies and methods using same |
| 06/28/2011 | US7968688 Antibodies that bind to the C35 polypeptide |
| 06/28/2011 | US7968687 CD19 binding agents and uses thereof |
| 06/28/2011 | US7968684 Polypeptides comprising antigen binding domains for diagnosis, prevention and treatment of inflammation, skin, respiratory, kidney, cardiovascular, nervous system and pancreatic disorder |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968512 Conjugates that contain the homeodomain of antennapedia |
| 06/28/2011 | US7968341 Sequence specific DNA recombination in eukaryotic cells |
| 06/28/2011 | US7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 06/28/2011 | US7968316 Method for the mass production of immunoglobulin Fc region deleted initial methionine residues |
| 06/28/2011 | US7968315 Production and purification of IL-29 |
| 06/28/2011 | US7968313 Selection of cells expressing heteromeric polypeptides |
| 06/28/2011 | US7968312 Production of polypeptides by improved secretion |
| 06/28/2011 | US7968311 Using transgenic cells for propagation of heterologous proteins; bioreactors |